
Metoprolol Succinate (47.5mg)
Active composition
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Metwon XR 50 Tablet is a once-daily, extended-release formulation of Metoprolol Succinate, a beta1-selective adrenergic receptor blocker indicated for the treatment of hypertension and chronic stable angina. This tablet is designed to provide a sustained release of the active ingredient over a 24-hour period, allowing for consistent blood pressure control and anginal relief. Metoprolol Succinate exerts its therapeutic effects by reducing the force and rate of cardiac contractions, thereby decreasing peripheral resistance and blood pressure. The tablet's controlled-release mechanism ensures a predictable and sustained pharmacokinetic profile, minimizing the risk of peak-trough fluctuations in plasma concentrations. As a result, Metwon XR 50 Tablet offers a reliable and convenient treatment option for patients requiring chronic therapy for hypertension and angina. Its once-daily dosing regimen simplifies treatment compliance, reducing the likelihood of medication errors and improving patient outcomes.
Alcohol & phenols
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metwon XR 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metwon XR 50 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Metwon XR 50 Tablet is safe to use in patients with kidney disease. No dose adjustment of Metwon XR 50 Tablet is recommended.
Exercise Caution
Metwon XR 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Metwon XR 50 Tablet should be used with caution in patients with liver disease. Dose adjustment of Metwon XR 50 Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Metwon XR 50 Tablet

Metoprolol Succinate (47.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Metwon XR 50 Tablet is a once-daily, extended-release formulation of Metoprolol Succinate, a beta1-selective adrenergic receptor blocker indicated for the treatment of hypertension and chronic stable angina. This tablet is designed to provide a sustained release of the active ingredient over a 24-hour period, allowing for consistent blood pressure control and anginal relief. Metoprolol Succinate exerts its therapeutic effects by reducing the force and rate of cardiac contractions, thereby decreasing peripheral resistance and blood pressure. The tablet's controlled-release mechanism ensures a predictable and sustained pharmacokinetic profile, minimizing the risk of peak-trough fluctuations in plasma concentrations. As a result, Metwon XR 50 Tablet offers a reliable and convenient treatment option for patients requiring chronic therapy for hypertension and angina. Its once-daily dosing regimen simplifies treatment compliance, reducing the likelihood of medication errors and improving patient outcomes.
Alcohol & phenols
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metwon XR 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metwon XR 50 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Metwon XR 50 Tablet is safe to use in patients with kidney disease. No dose adjustment of Metwon XR 50 Tablet is recommended.
Exercise Caution
Metwon XR 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Metwon XR 50 Tablet should be used with caution in patients with liver disease. Dose adjustment of Metwon XR 50 Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Metwon XR 50 Tablet















